Cabazitaxel, sold under the brand name Jevtana, is a semi-synthetic derivative of a natural taxoid. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.
via Wikipedia infobox
via PubMed
{{Infobox drug | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 460123299 | image = Cabazitaxel2DACS.svg | image_class = skin-invert-image | width = | alt = | caption =
| pronounce = | tradename = Jevtana | Drugs.com = | MedlinePlus = a611009 | DailyMedID = Cabazitaxel | pregnancy_AU = D | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = Intravenous | class = | ATC_prefix = L01 | ATC_suffix = CD04 | ATC_supplemental =
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).